Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Silverback Therapeutics, Inc. (SBTX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
5.48+0.05 (+0.92%)
At close: 04:00PM EDT
5.13 -0.35 (-6.39%)
After hours: 06:24PM EDT
Advertisement
Advertisement
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Total Revenue
0
0
0
0
0
Operating Expense
90,684
89,584
32,918
24,067
18,320
Operating Income
-90,684
-89,584
-32,918
-24,067
-18,320
Net Non Operating Interest Income Expense
509
106
-29
100
43
Other Income Expense
-
-
-
-
698
Pretax Income
-90,175
-89,478
-32,947
-23,967
-17,579
Net Income Common Stockholders
-90,175
-89,478
-32,947
-23,967
-17,579
Diluted NI Available to Com Stockholders
-90,175
-89,478
-32,947
-23,967
-17,579
Basic EPS
-
-2.56
-11.33
-4.90
-3.59
Diluted EPS
-
-2.56
-11.33
-4.90
-3.59
Basic Average Shares
-
34,926
2,908
4,893
4,893
Diluted Average Shares
-
34,926
2,908
4,893
4,893
Total Operating Income as Reported
-90,684
-89,584
-32,918
-24,067
-18,320
Total Expenses
90,684
89,584
32,918
24,067
18,320
Net Income from Continuing & Discontinued Operation
-90,175
-89,478
-32,947
-23,967
-17,579
Normalized Income
-90,175
-89,478
-32,947
-23,967
-17,579
Interest Income
-
-
-29
100
43
Net Interest Income
509
106
-29
100
43
EBIT
-90,684
-89,584
-32,918
-24,067
-18,320
EBITDA
-89,865
-
-
-
-
Reconciled Depreciation
819
783
637
544
480
Net Income from Continuing Operation Net Minority Interest
-90,175
-89,478
-32,947
-23,967
-17,579
Normalized EBITDA
-89,865
-88,801
-32,281
-23,523
-17,840
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
Advertisement
Advertisement